Author Question: What is the breath termination for a CareFusion V.I.P. Bird Infant-Pediatric Ventilator set to ... (Read 64 times)

saliriagwu

  • Hero Member
  • *****
  • Posts: 537
What is the breath termination for a CareFusion V.I.P. Bird Infant-Pediatric Ventilator set to de-liver pressure support at tidal volume = 250 mL and peak expiratory flow 15 L/min?
 
  a. Time cycle at 1 second c. Flow cycle at 1 L/min
  b. Time cycle at 1.25 second d. Flow cycle at 3.75 L/min

Question 2

With a CareFusion V.I.P. Bird Infant-Pediatric Ventilator, a flashing pressure-support display during spontaneous breathing can be caused by which of the following?
 
  a. Pressure support level too high c. Leaks around the artificial airway
  b. High-pressure alarm threshold met d. Decreased volume delivery



Kedrick2014

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

ANS: D
Breaths in the volume-cycled mode on the CareFusion V.I.P. Bird Infant-Pediatric Ventilator are terminated using flow-cycling. For delivered tidal volume greater than 200 mL, the flow-cycle value is 25 of peak flow.

Answer to Question 2

ANS: C
Leaks in the system, including around the artificial airway, may result in excessive inspiratory time. This would cause the ventilator to time-cycle instead of flow-cycle the pressure-support breaths.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

For a complete list of videos, visit our video library